Get the latest Science News and Discoveries
Quadruple therapies and the future of multiple myeloma treatment - EurekAlert
The treatment landscape for multiple myeloma is shifting rapidly, with new patients increasingly being treated with a four-part drug combination that includes a new immunotherapy agent. Over the last decade, options have evolved from double, to triple to quadruple combination therapies. What do these new options mean for patients, and how will treatment change in the future?
None
Or read this on Eureka Alert